Somnus Therapeutics, Inc.
Insomnia Therapeutics
Somnus Therapeautics Insomnia
Somnus Therapeautics Insomnia Somnus Therapeutics Somnus Therapeautics Insomnia Somnus Therapeutics Insomnia Product Somnus Therapeautics Insomnia Insomnia Information from Somnus Therapeutics Somnus Therapeautics Insomnia Somnus Therapeutics News and Events Somnus Therapeautics Insomnia Contact the Insomnia Specialists Somnus Therapeutics Somnus Therapeautics Insomnia
Somnus Therapeautics Insomnia
  overview
Somnus Therapeutics Insomnia
  about
Somnus Therapeutics Insomnia
  sleep & insomnia
Somnus Therapeutics Insomnia
  press releases
Somnus Therapeutics Insomnia
  information
Somnus Therapeutics Insomnia
  management
 
  publications
  directions
  board of directors
  scientific advisors
         

           Overview of Somnus Therapeutics Inc
 

Somnus Therapeutics, Inc. (Bedminster, NJ) is a private drug development company formed by Care Capital LLC. The company is developing an improved therapeutic to address the top need of insomnia patients: preventing mid-night awakenings without next-day hangovers.

Somnus sees significant opportunity within the multi-billion dollar insomnia market for a new treatment that delivers improved satisfaction to patients and an improved risk/reward profile to investors. To those ends, the company has licensed from SkyePharma PLC (LSE: SKP) a new controlled-release formulation of an established non-benzodiazepine hypnotic pharmaceutical (SKP-1041).

By leveraging the development of a chemical entity from the most successful class of current insomnia drugs with

  • technical advances in formulation
  • controlled-release
  • clinical testing,
we believe we can speed development and reduce clinical development costs, thus increasing return on investment.







Somnus is the Latin name for the Greek god Hypnos, a son of the goddess Nyx (night) and the personification of sleep.
 
Somnus Therapeautics Insomnia
Somnus Therapeautics Insomnia